Hypertension (HTN) remains a principal cause of premature death worldwide. The goal of this learning activity is to provide doctors with a comprehensive review of renal denervation therapy (RDN) and its role in improving blood pressure control in patients with HTN. Upon completing this module, participants will have a better understanding of the following aspects:

• Epidemiology and burden of HTN
• Current treatment options for HTN
• The role of RDN in managing HTN
• Guidelines and recommendations

CPD Reviewer:
Clin Assoc Prof Chin Chee Tang
Senior Consultant Cardiologist
National Heart Centre Singapore

Who should participate:

• Doctors

NOTE :
Please watch the video before attempting the assessment questions.

Terms & Conditions:

• Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
• MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.

Sponsored by